TOPELIA AUSTRALIA
Topelia Australia has extensive expertise in commercializing the revolutionary triple therapy cure for peptic ulcers.
TOPELIA AUSTRALIA
Industry:
Fitness Health Care Wellness
Website Url:
http://www.topeliaaustralia.com
Status:
Active
Official Site Inspections
http://www.topeliaaustralia.com
- Host name: a290d26420470737c.awsglobalaccelerator.com
- IP address: 15.197.133.181
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Topelia Australia"
Topelia Aust Limited
Topelia Aust Pty Limited (ABN 36 652 771 670) (Topelia) is a public, unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) named Ziverdox-T directed at …See details»
About Topelia | Topelia Aust Limited - Topelia Aust Pty Limited
About Topelia. Topelia Aust Limited (ABN 36 652 771 670) is a pioneering, public, unlisted biotechnology company committed to developing and commercialising its proprietary Antiviral …See details»
Topelia Australia - Crunchbase Company Profile & Funding
Topelia Australia has extensive expertise in commercializing the revolutionary triple therapy cure for peptic ulcers.See details»
Topelia Australia - VentureRadar
"Topelia Australia was founded based on the wealth of experience in commercialising the ground-breaking triple therapy cure for peptic ulcers which has saved over 18 thousand lives in …See details»
Topelia Australia - AusBiotech
Topelia Australia . Topelia Aust Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy for coronavirus infection.See details»
Topelia Overview | SignalHire Company Profile
Topelia Aust Limited (ABN 36 652 771 670) (Topelia) is a public, unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»
Investors | Topelia Aust Limited - Topelia Aust Pty Limited
Topelia Aust Pty Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»
Contact Us | Topelia Aust Limited
Topelia Aust Limited 1/229 Great N Rd, Five Dock, NSW 2046 ABN: 36 652 771 670 Email: [email protected]See details»
Topelia Australia - PitchBook
Topelia Australia General Information Description. Developer of antiviral triple therapy intended to commercialize the triple therapy cure for peptic ulcers. The company's product offers antiviral …See details»
Topelia Australia - Owler
Topelia Australia is a Private company. David Fox is the CEO of Topelia Australia. Topelia Australia has received a total of $25M in funding. Topelia Australia has an estimated revenue …See details»
Topelia Australia | VentureRadar
Website: https://www.topeliaaustralia.com/ Develops and commercialises a triple therapy cure for peptic ulcers, saving lives and reducing government medical costs.See details»
Topelia Australia launches US$25M Series A call for COVID-19
Nov 30, 2021 Topelia Australia owns the patent rights to the novel Antiviral Triple Therapy. Visit https://TopeliaAustralia.com. Professor Borody has more than 190 patents and applications, 3 …See details»
Topelia Aust Ltd. (Topelia Aust Ltd.) - 药物管线_专利_临床试验_投 …
Visit . Professor Borody has more than 190 patents and applications, 3 FDA-approved drugs on the market, and more than 300 peer-reviewed papers published. Media contact: …See details»
Board of Directors | Topelia Aust Limited - Topelia Aust Pty Limited
Prof Borody is most famous for his ground-breaking work developing the triple therapy cure for peptic ulcers in 1987 1, which has saved hundreds of thousands of lives, and the Australian …See details»
Topelia Australia - Techboard
Feb 21, 2022 Elevator Pitch: Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment program …See details»
Topelia Australia launches US$25M Series A call for COVID-19 ATT ...
Oct 15, 2021 The company is raising USD$25 million from investors in Australia, Asia and USA. SYDNEY, Oct 14, 2021 - (ACN Newswire) - Topelia Australia, a biotech company established …See details»
Therapeutics: Our partnerships and collaborations
Topelia Aust Pty Limited (ABN 36 652 771 670) (Topelia) is an unlisted biotechnology company focused on developing and commercialising its proprietary Antiviral Triple Therapy (ATT) …See details»
Topelia Australia launches US$25M Series A call for COVID-19 ATT ...
Oct 14, 2021 Professor Borody has more than 190 patents and applications, 3 FDA-approved drugs on the market, and more than 300 peer-reviewed papers published. Topelia Australia …See details»
Overview of Topelia | Topelia Aust Limited - Topelia Aust Pty Limited
Overview of Topelia. Topelia Aust Limited is dedicated to developing and commercialising its proprietary Antiviral Triple Therapy (ATT), known as TPL101.Topelia's strategic approach …See details»
Topelia Australia launches US$25M Series A call for COVID-19 ATT ...
- Topelia announces US$25 mil Series A capital raise to fund manufacture and clinical trials of the COVID-19 Antiviral Triple Therapy (ATT). - Topelia has secured exclusive global patent rights …See details»